5 Best Small-Cap Growth Stocks to Invest In

Page 5 of 5

1. Neurocrine Biosciences, Inc. (NASDAQ:NBIX)

Number of Hedge Fund Investors As Of Q4 2023 end: 55

Neurocrine Biosciences, Inc. (NASDAQ:NBIX) is yet another healthcare company. It develops treatments for ailments such as Parkinson’s disease and adrenal system disorders. The shares are rated Strong Buy on average, and the average analyst share price target is $148.54.

For their December quarter of 2023 shareholdings, 55 out of the 933 hedge funds covered by Insider Monkey had invested in the company. Neurocrine Biosciences, Inc. (NASDAQ:NBIX)’s biggest investor among these is Jim Simons’s Renaissance Technologies due to its $262 million stake.

Follow Neurocrine Biosciences Inc (NASDAQ:NBIX)

Disclosure: None. You can also take a look at 13 Best Consumer Staples Dividend Stocks To Buy Now and 15 Best Long Term Care Insurance Companies Heading into 2024.

Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

[/daily-newsletter

Follow Insider Monkey on Twitter

Page 5 of 5